Cardiff-based Antiverse, a biotechnology company developing AI-powered therapeutic antibody discovery tools, has closed a $9.3 million Series A financing to expand its computational platform and advance lead programmes toward in vivo studies. The round was led by Soulmates Ventures with participation from Innovation Investment Capital, DOMiNO Ventures, and existing backers including DBW, Kadmos Capital and […]<br /> This story continues at The Next Web [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]
Amazon's new Bio Discovery tool can design and run experiments for antibody research and drug synthesis. [...]
The tenth generation of the Apple Watch came and went without much fanfare last year, and the arrival of the Series 11 is similarly subdued. Not much appears to have changed with Apple’s smartwatch, [...]
Paramount Skydance CEO David Ellison is apparently still hopeful that investors will approve his $108.4 billion hostile takeover of Warner Bros. Discovery. Paramount Skydance announced Thursday that i [...]
Paramount Skydance and Warner Bros. Discovery are officially merging. The studio paid Netflix the $2.8 billion termination fee it was owed for breaking its original deal to buy Warner Bros. earlier to [...]
Apple’s September event put the spotlight on iPhones, but the Apple Watch Series 11 quietly picked up some big quality-of-life changes. The new watch looks the same as the Series 10, but there are m [...]
Paramount Skydance, apparently now in a state of permanent merger, plans to make a bid to acquire Warner Bros. Discovery, The Wall Street Journal reports. The company was recently formed following Sky [...]